Quantum X Labs successfully demonstrated its Qatacomb quantum encryption scheme on IBM's 156-qubit Heron r2 quantum processor, recovering an encrypted image with high accuracy while preventing any usable information leakage to unauthorized parties. Unlike traditional encryption relying on computational difficulty, Qatacomb's security is based on quantum state properties, offering information-theoretic privacy that remains secure regardless of an adversary's computing power. This marks a significant step from theory to practical testing on real quantum hardware, highlighting potential future-proof quantum encryption applications.
Quantum X Labs' breakthrough in quantum encryption provides context for technology sector performance on Pluang. For readers following Technology stocks, here is Pluang's market snapshot as of Nov 02, 2026 19:21 WIB: out of 150 priced stocks, 96 rose and 40 fell. Notable movers include Unity Software Inc (U) at USD 38.64 with a 1-day change of +2.49% and a typical hold time of 51 days, DigitalOcean Holdings Inc (DOCN) at USD 91.71 with +2.45% and 44 days hold time, and Celestica Inc (CLS) at USD 272.00 with +2.41% and 34 days hold time.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...
Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...
Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...
Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...
Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...
